MCHI 📈 iShares MSCI China - Overview
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B6719 • China Region
MCHI: Chinese, Stocks, Equities, Securities
The iShares MSCI China ETF, listed on the NASDAQ under the ticker MCHI, is designed to track the performance of the Chinese equity market, focusing on the top 85% of companies by market capitalization. This ETF typically invests at least 80% of its assets in the component securities of its underlying index, which includes a mix of H-shares and B-shares. By doing so, it aims to replicate the performance of the broader Chinese equity market, providing investors with exposure to the country's economic growth. The underlying index is free float-adjusted and market capitalization-weighted, ensuring that the fund's holdings are proportional to the market capitalization of the underlying companies.
As a non-diversified fund, the iShares MSCI China ETF may have a more concentrated portfolio compared to diversified funds, which can result in higher volatility. However, this concentration also allows the fund to more closely track the performance of the Chinese equity market. The fund is listed in the United States and is classified as an exchange-traded fund (ETF), providing investors with the benefits of trading flexibility and transparency. With its ISIN code US46429B6719, the fund is easily identifiable and accessible to investors worldwide. The fund's category is specifically focused on China, making it an attractive option for investors looking to gain exposure to the Chinese economy.
The iShares MSCI China ETF is part of the broader iShares family of ETFs, which is managed by BlackRock, one of the world's largest asset managers. Investors can find more information about the fund on the iShares website, which provides detailed information on the fund's holdings, performance, and other relevant data. By investing in this ETF, investors can gain exposure to the Chinese equity market, which has been one of the fastest-growing major economies in the world. The fund's focus on the top 85% of companies by market capitalization ensures that investors are exposed to the largest and most liquid companies in the Chinese market, providing a relatively stable and diversified portfolio.
Additional Sources for MCHI ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MCHI ETF Overview
Market Cap in USD | 5,507m |
Category | China Region |
TER | 0.59% |
IPO / Inception | 2011-03-29 |
MCHI ETF Ratings
Growth 5y | -21.9% |
Fundamental | - |
Dividend | 43.4% |
Rel. Strength Industry | -21.5 |
Analysts | - |
Fair Price Momentum | 44.27 USD |
Fair Price DCF | - |
MCHI Dividends
Dividend Yield 12m | 0.40% |
Yield on Cost 5y | 0.33% |
Annual Growth 5y | 8.88% |
Payout Consistency | 91.1% |
MCHI Growth Ratios
Growth Correlation 3m | -75% |
Growth Correlation 12m | 83% |
Growth Correlation 5y | -77.1% |
CAGR 5y | -3.83% |
CAGR/Mean DD 5y | -0.11 |
Sharpe Ratio 12m | 0.68 |
Alpha | 4.68 |
Beta | 0.62 |
Volatility | 34.43% |
Current Volume | 695.2k |
Average Volume 20d | 2943k |
As of December 27, 2024, the stock is trading at USD 47.71 with a total of 695,200 shares traded.
Over the past week, the price has changed by +2.85%, over one month by +4.83%, over three months by +5.52% and over the past year by +23.41%.
Neither. Based on ValueRay Analyses, iShares MSCI China is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -21.90 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCHI as of December 2024 is 44.27. This means that MCHI is currently overvalued and has a potential downside of -7.21%.
iShares MSCI China has no consensus analysts rating.
According to ValueRays Forecast Model, MCHI iShares MSCI China will be worth about 48.6 in December 2025. The stock is currently trading at 47.71. This means that the stock has a potential upside of +1.93%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 48.6 | 1.9% |